Dr. Ethan Yang is a physician-scientist, entrepreneur, and investor with a strong background in biomedical engineering and clinical innovation. He earned both his bachelor’s and master’s degrees in bioengineering from Stanford University in 2008 before obtaining dual MD and PhD degrees through the University of Miami’s Medical Scientist Training Program.

Throughout his career, Dr. Yang has demonstrated expertise in surgical innovation, biomedical engineering, and strategic investments, contributing to multiple successful acquisitions and FDA-approved technologies. He served as Chief Medical Officer at Micromedtech, a medical device company, where he led the development of a flow disruptor for brain aneurysms and a percutaneous carotid artery revascularization device.

Building on his expertise in cardiovascular innovation, Dr. Yang founded Nanovascular Technologies, where he leads the development of advanced heart failure monitoring devices aimed at reducing hospitalizations and improving patient outcomes. He is also spearheading the development of an AI-powered triage solution to streamline emergency room workflows, enhance patient care, and lower healthcare costs.

Beyond his professional work, Ethan has traveled to 194 out of 195 countries, driven by his passion for exploration and photography. His global experiences have provided firsthand insight into diverse healthcare challenges, shaping his perspective on the evolving needs of modern medicine.